Masanori Kitaichi

Masanori Kitaichi

Auto-generated profile, based on publicly available information

Masanori Kitaichi

Department of Pathology, National Hospital Organization, Kinki-Chuo Chest Medical Center, 1180 Nagasone-Cho, Kita-Ku, Sakai City, Osaka 591-8555, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Respiratory Investigation
Verified
Journal Article
Open access
TAToru Arai
Toru Arai
YIYoshikazu Inoue
Yoshikazu Inoue
YSYumiko Sasaki
Yumiko Sasaki
KTKazunobu Tachibana
Kazunobu Tachibana
KNKeiko Nakao
Keiko Nakao
SHSeiji Hayashi
Seiji Hayashi
BackgroundIdiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with a poor prognosis. Recently, pirfenidone was reported to slow the rate of decline in vital capacity and improve progression-free survival in IPF. The purpose of this study was to clarify the factors that predicted a good response to pirfenidone, as well as its adverse effects.MethodsForty-one IPF cases, treated with pirfenidone from January 2009 to January 2011, were enrolled in this investigation. Disease severity was classified into grades I–IV, as defined by the Japanese Respiratory Society (JRS). Short-term responsiveness to pirfenidone was evaluated by the modified criteria of the JRS. Predictors of nausea, anorexia, or both that represented important adverse effects were examined by multivariate Cox proportional hazard analyses. Predictors of short-time responsiveness were examined by multivariate logistic regression analyses.ResultsDiagnosed by a surgical lung biopsy (SLB), the mild cases of grade I/II were predictors of good, short-term responsiveness. Patients taking acid-secretion inhibitors, including proton pump inhibitors and histamine H2-receptor antagonists, showed less anorexia, nausea, or both. Only 1 case was administered drugs to activate gastrointestinal motility.ConclusionsWe concluded that IPF patients with a mild disease, diagnosis by SLB, or both showed indications of a good response to pirfenidone. In addition, acid-secretion inhibitors may reduce the frequency of anorexia, nausea, or both from pirfenidone

22 April 2015 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
YIYukie Ito
Yukie Ito
TATakuma Akimoto
Takuma Akimoto
KCKazutoshi Cho
Kazutoshi Cho
MYMasafumi Yamada
Masafumi Yamada
MTMishie Tanino
Mishie Tanino
YKYoshikazu Kinugawa
Yoshikazu Kinugawa

1 January 2015 in Internal Medicine
Verified
Journal Article
Closed access
NONaoki Omachi
Naoki Omachi
TKTomoya Kawaguchi
Tomoya Kawaguchi
SSShigeki Shimizu
Shigeki Shimizu
TOTomohisa Okuma
Tomohisa Okuma
MKMasanori Kitaichi
Masanori Kitaichi
AMAkihide Matsumura
Akihide Matsumura
This report describes the case of a 23-year-old man with a mediastinal teratoma. Five months before admission, a chest radiograph during a routine health checkup was normal. Four months before admission, the patient developed sudden onset of mild right-sided chest pain. He gradually developed dyspnea and was admitted to our hospital. Computed tomography revealed a giant tumor that was markedly compressing the right atrium. Urgent surgery was performed, and a ruptured, benign mature teratoma was diagnosed. Mature mediastinal teratomas are benign tumors, but they can rupture and have the potential to grow rapidly, potentially leading to life-threatening complications.

1 January 2016 in Respiratory Medicine Case Reports
Verified
Journal Article
Open access
HTHiromi Tomioka
Hiromi Tomioka
TKToshihiko Kaneda
Toshihiko Kaneda
EKEiji Katsuyama
Eiji Katsuyama
MKMasanori Kitaichi
Masanori Kitaichi
HMHiroshi Moriyama
Hiroshi Moriyama
ESEiichi Suzuki
Eiichi Suzuki
The parenchymal lung diseases caused by metal inhalation include interstitial fibrosis, giant cell interstitial pneumonitis, chemical pneumonitis, and granulomatous disease, among others. We reported two cases of granulomatous lung disease with occupational exposure to metal dusts other than beryllium. They had worked in the battery manufacturing industry for 7 years and in an aluminum-processing factory for 6 years, respectively. Chest high-resolution computed tomography showed diffuse micronodules, and histology of video-assisted lung biopsy specimens revealed granulomatous lesions in the pulmonary interstitium. Results of microscopic examination of the tissue with special stains for mycobacteria and fungi were negative. Analysis by an electron probe microanalyzer with a wavelength-dispersive spectrometer (EPMA-WDS) confirmed the presence of silicon, iron, aluminum, and titanium in the granulomas. In particular, aluminum was distributed in a relatively high concentration in the granulomatous lesions. Although chronic beryllium disease is well known as an occupational granulomatous lung disease, much less is known about the other metals that cause granulomatous reactions in humans. Our report pointed out manifestations similar to beryllium disease after other metal dust exposures, in particular aluminum exposure. To our knowledge, this is the first report showing two-dimensional images of elemental mapping in granulomatous lesions associated with metal inhalation using EPMA-WDS.

1 January 2014 in Respiratory Investigation
Verified
Journal Article
Closed access
YMYoshinobu Matsuda
Yoshinobu Matsuda
KTKazunobu Tachibana
Kazunobu Tachibana
YSYumiko Sasaki
Yumiko Sasaki
KTKazunari Tsuyuguchi
Kazunari Tsuyuguchi
MKMasanori Kitaichi
Masanori Kitaichi
YIYoshikazu Inoue
Yoshikazu Inoue

1 April 2014
Verified
Journal Article
Closed access
ATAkihiro Tamiya
Akihiro Tamiya
AMAkihide Matsumura
Akihide Matsumura
TTTaisuke Tsuji
Taisuke Tsuji
MMMasahiro Morimoto
Masahiro Morimoto
KAKazuhiro Asami
Kazuhiro Asami
TKTomoya Kawaguchi
Tomoya Kawaguchi